Global Injection Influenza Vaccine Market Research Report 2023

Global Injection Influenza Vaccine Market Research Report 2023

Table of Contents
1 Injection Influenza Vaccine Market Overview
1.1 Product Overview and Scope of Injection Influenza Vaccine
1.2 Injection Influenza Vaccine Segment by Type
1.2.1 Global Injection Influenza Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Injection Influenza Vaccine Segment by Application
1.3.1 Global Injection Influenza Vaccine Market Value by Application: (2023-2029)
1.3.2 6 Months to 3 Years
1.3.3 > 3 Years
1.4 Global Injection Influenza Vaccine Market Size Estimates and Forecasts
1.4.1 Global Injection Influenza Vaccine Revenue 2018-2029
1.4.2 Global Injection Influenza Vaccine Sales 2018-2029
1.4.3 Global Injection Influenza Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Injection Influenza Vaccine Market Competition by Manufacturers
2.1 Global Injection Influenza Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Injection Influenza Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Injection Influenza Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Injection Influenza Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Injection Influenza Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Injection Influenza Vaccine, Product Type & Application
2.7 Injection Influenza Vaccine Market Competitive Situation and Trends
2.7.1 Injection Influenza Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Injection Influenza Vaccine Players Market Share by Revenue
2.7.3 Global Injection Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Injection Influenza Vaccine Retrospective Market Scenario by Region
3.1 Global Injection Influenza Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Injection Influenza Vaccine Global Injection Influenza Vaccine Sales by Region: 2018-2029
3.2.1 Global Injection Influenza Vaccine Sales by Region: 2018-2023
3.2.2 Global Injection Influenza Vaccine Sales by Region: 2024-2029
3.3 Global Injection Influenza Vaccine Global Injection Influenza Vaccine Revenue by Region: 2018-2029
3.3.1 Global Injection Influenza Vaccine Revenue by Region: 2018-2023
3.3.2 Global Injection Influenza Vaccine Revenue by Region: 2024-2029
3.4 North America Injection Influenza Vaccine Market Facts & Figures by Country
3.4.1 North America Injection Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Injection Influenza Vaccine Sales by Country (2018-2029)
3.4.3 North America Injection Influenza Vaccine Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Injection Influenza Vaccine Market Facts & Figures by Country
3.5.1 Europe Injection Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Injection Influenza Vaccine Sales by Country (2018-2029)
3.5.3 Europe Injection Influenza Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Injection Influenza Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Injection Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Injection Influenza Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Injection Influenza Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Injection Influenza Vaccine Market Facts & Figures by Country
3.7.1 Latin America Injection Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Injection Influenza Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Injection Influenza Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Injection Influenza Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Injection Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Injection Influenza Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Injection Influenza Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Injection Influenza Vaccine Sales by Type (2018-2029)
4.1.1 Global Injection Influenza Vaccine Sales by Type (2018-2023)
4.1.2 Global Injection Influenza Vaccine Sales by Type (2024-2029)
4.1.3 Global Injection Influenza Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Injection Influenza Vaccine Revenue by Type (2018-2029)
4.2.1 Global Injection Influenza Vaccine Revenue by Type (2018-2023)
4.2.2 Global Injection Influenza Vaccine Revenue by Type (2024-2029)
4.2.3 Global Injection Influenza Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Injection Influenza Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Injection Influenza Vaccine Sales by Application (2018-2029)
5.1.1 Global Injection Influenza Vaccine Sales by Application (2018-2023)
5.1.2 Global Injection Influenza Vaccine Sales by Application (2024-2029)
5.1.3 Global Injection Influenza Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Injection Influenza Vaccine Revenue by Application (2018-2029)
5.2.1 Global Injection Influenza Vaccine Revenue by Application (2018-2023)
5.2.2 Global Injection Influenza Vaccine Revenue by Application (2024-2029)
5.2.3 Global Injection Influenza Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Injection Influenza Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sanofi Injection Influenza Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 CSL Injection Influenza Vaccine Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 GSK Injection Influenza Vaccine Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Corporation Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Viatris Injection Influenza Vaccine Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 AstraZeneca Injection Influenza Vaccine Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Hualan Bio
6.6.1 Hualan Bio Corporation Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Hualan Bio Injection Influenza Vaccine Product Portfolio
6.6.5 Hualan Bio Recent Developments/Updates
6.7 Changchun Institute of Biological
6.6.1 Changchun Institute of Biological Corporation Information
6.6.2 Changchun Institute of Biological Description and Business Overview
6.6.3 Changchun Institute of Biological Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Changchun Institute of Biological Injection Influenza Vaccine Product Portfolio
6.7.5 Changchun Institute of Biological Recent Developments/Updates
6.8 Sinovac
6.8.1 Sinovac Corporation Information
6.8.2 Sinovac Description and Business Overview
6.8.3 Sinovac Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Sinovac Injection Influenza Vaccine Product Portfolio
6.8.5 Sinovac Recent Developments/Updates
6.9 Jiangsu GDK
6.9.1 Jiangsu GDK Corporation Information
6.9.2 Jiangsu GDK Description and Business Overview
6.9.3 Jiangsu GDK Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Jiangsu GDK Injection Influenza Vaccine Product Portfolio
6.9.5 Jiangsu GDK Recent Developments/Updates
6.10 KM Biologics
6.10.1 KM Biologics Corporation Information
6.10.2 KM Biologics Description and Business Overview
6.10.3 KM Biologics Injection Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 KM Biologics Injection Influenza Vaccine Product Portfolio
6.10.5 KM Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Injection Influenza Vaccine Industry Chain Analysis
7.2 Injection Influenza Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Injection Influenza Vaccine Production Mode & Process
7.4 Injection Influenza Vaccine Sales and Marketing
7.4.1 Injection Influenza Vaccine Sales Channels
7.4.2 Injection Influenza Vaccine Distributors
7.5 Injection Influenza Vaccine Customers
8 Injection Influenza Vaccine Market Dynamics
8.1 Injection Influenza Vaccine Industry Trends
8.2 Injection Influenza Vaccine Market Drivers
8.3 Injection Influenza Vaccine Market Challenges
8.4 Injection Influenza Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Injection Influenza Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Injection Influenza Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Injection Influenza Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Injection Influenza Vaccine Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Injection Influenza Vaccine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Injection Influenza Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Injection Influenza Vaccine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Injection Influenza Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Injection Influenza Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Injection Influenza Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Injection Influenza Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Injection Influenza Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Injection Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injection Influenza Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Injection Influenza Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Injection Influenza Vaccine Sales by Region (2018-2023) & (K Units)
Table 18. Global Injection Influenza Vaccine Sales Market Share by Region (2018-2023)
Table 19. Global Injection Influenza Vaccine Sales by Region (2024-2029) & (K Units)
Table 20. Global Injection Influenza Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Injection Influenza Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Injection Influenza Vaccine Revenue Market Share by Region (2018-2023)
Table 23. Global Injection Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Injection Influenza Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Injection Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Injection Influenza Vaccine Sales by Country (2018-2023) & (K Units)
Table 27. North America Injection Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 28. North America Injection Influenza Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Injection Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Injection Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Injection Influenza Vaccine Sales by Country (2018-2023) & (K Units)
Table 32. Europe Injection Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 33. Europe Injection Influenza Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Injection Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Injection Influenza Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Injection Influenza Vaccine Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Injection Influenza Vaccine Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Injection Influenza Vaccine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Injection Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Injection Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Injection Influenza Vaccine Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Injection Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Injection Influenza Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Injection Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Injection Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Injection Influenza Vaccine Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Injection Influenza Vaccine Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Injection Influenza Vaccine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Injection Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Injection Influenza Vaccine Sales (K Units) by Type (2018-2023)
Table 51. Global Injection Influenza Vaccine Sales (K Units) by Type (2024-2029)
Table 52. Global Injection Influenza Vaccine Sales Market Share by Type (2018-2023)
Table 53. Global Injection Influenza Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Injection Influenza Vaccine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Injection Influenza Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Injection Influenza Vaccine Revenue Market Share by Type (2018-2023)
Table 57. Global Injection Influenza Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Injection Influenza Vaccine Price (US$/Unit) by Type (2018-2023)
Table 59. Global Injection Influenza Vaccine Price (US$/Unit) by Type (2024-2029)
Table 60. Global Injection Influenza Vaccine Sales (K Units) by Application (2018-2023)
Table 61. Global Injection Influenza Vaccine Sales (K Units) by Application (2024-2029)
Table 62. Global Injection Influenza Vaccine Sales Market Share by Application (2018-2023)
Table 63. Global Injection Influenza Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global Injection Influenza Vaccine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Injection Influenza Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Injection Influenza Vaccine Revenue Market Share by Application (2018-2023)
Table 67. Global Injection Influenza Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global Injection Influenza Vaccine Price (US$/Unit) by Application (2018-2023)
Table 69. Global Injection Influenza Vaccine Price (US$/Unit) by Application (2024-2029)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Sanofi Injection Influenza Vaccine Product
Table 74. Sanofi Recent Developments/Updates
Table 75. CSL Corporation Information
Table 76. CSL Description and Business Overview
Table 77. CSL Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. CSL Injection Influenza Vaccine Product
Table 79. CSL Recent Developments/Updates
Table 80. GSK Corporation Information
Table 81. GSK Description and Business Overview
Table 82. GSK Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. GSK Injection Influenza Vaccine Product
Table 84. GSK Recent Developments/Updates
Table 85. Viatris Corporation Information
Table 86. Viatris Description and Business Overview
Table 87. Viatris Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Viatris Injection Influenza Vaccine Product
Table 89. Viatris Recent Developments/Updates
Table 90. AstraZeneca Corporation Information
Table 91. AstraZeneca Description and Business Overview
Table 92. AstraZeneca Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. AstraZeneca Injection Influenza Vaccine Product
Table 94. AstraZeneca Recent Developments/Updates
Table 95. Hualan Bio Corporation Information
Table 96. Hualan Bio Description and Business Overview
Table 97. Hualan Bio Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Hualan Bio Injection Influenza Vaccine Product
Table 99. Hualan Bio Recent Developments/Updates
Table 100. Changchun Institute of Biological Corporation Information
Table 101. Changchun Institute of Biological Description and Business Overview
Table 102. Changchun Institute of Biological Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Changchun Institute of Biological Injection Influenza Vaccine Product
Table 104. Changchun Institute of Biological Recent Developments/Updates
Table 105. Sinovac Corporation Information
Table 106. Sinovac Description and Business Overview
Table 107. Sinovac Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Sinovac Injection Influenza Vaccine Product
Table 109. Sinovac Recent Developments/Updates
Table 110. Jiangsu GDK Corporation Information
Table 111. Jiangsu GDK Description and Business Overview
Table 112. Jiangsu GDK Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Jiangsu GDK Injection Influenza Vaccine Product
Table 114. Jiangsu GDK Recent Developments/Updates
Table 115. KM Biologics Corporation Information
Table 116. KM Biologics Description and Business Overview
Table 117. KM Biologics Injection Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. KM Biologics Injection Influenza Vaccine Product
Table 119. KM Biologics Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Injection Influenza Vaccine Distributors List
Table 123. Injection Influenza Vaccine Customers List
Table 124. Injection Influenza Vaccine Market Trends
Table 125. Injection Influenza Vaccine Market Drivers
Table 126. Injection Influenza Vaccine Market Challenges
Table 127. Injection Influenza Vaccine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Injection Influenza Vaccine
Figure 2. Global Injection Influenza Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Injection Influenza Vaccine Market Share by Type in 2022 & 2029
Figure 4. Trivalent Influenza Vaccine Product Picture
Figure 5. Quadrivalent Influenza Vaccine Product Picture
Figure 6. Global Injection Influenza Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Injection Influenza Vaccine Market Share by Application in 2022 & 2029
Figure 8. 6 Months to 3 Years
Figure 9. > 3 Years
Figure 10. Global Injection Influenza Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Injection Influenza Vaccine Market Size (2018-2029) & (US$ Million)
Figure 12. Global Injection Influenza Vaccine Sales (2018-2029) & (K Units)
Figure 13. Global Injection Influenza Vaccine Average Price (US$/Unit) & (2018-2029)
Figure 14. Injection Influenza Vaccine Report Years Considered
Figure 15. Injection Influenza Vaccine Sales Share by Manufacturers in 2022
Figure 16. Global Injection Influenza Vaccine Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Injection Influenza Vaccine Players: Market Share by Revenue in 2022
Figure 18. Injection Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Injection Influenza Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Injection Influenza Vaccine Sales Market Share by Country (2018-2029)
Figure 21. North America Injection Influenza Vaccine Revenue Market Share by Country (2018-2029)
Figure 22. U.S. Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Injection Influenza Vaccine Sales Market Share by Country (2018-2029)
Figure 25. Europe Injection Influenza Vaccine Revenue Market Share by Country (2018-2029)
Figure 26. Germany Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Injection Influenza Vaccine Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Injection Influenza Vaccine Revenue Market Share by Region (2018-2029)
Figure 33. China Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Taiwan Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Philippines Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Injection Influenza Vaccine Sales Market Share by Country (2018-2029)
Figure 44. Latin America Injection Influenza Vaccine Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Injection Influenza Vaccine Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Injection Influenza Vaccine Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. U.A.E Injection Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Injection Influenza Vaccine by Type (2018-2029)
Figure 54. Global Revenue Market Share of Injection Influenza Vaccine by Type (2018-2029)
Figure 55. Global Injection Influenza Vaccine Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Injection Influenza Vaccine by Application (2018-2029)
Figure 57. Global Revenue Market Share of Injection Influenza Vaccine by Application (2018-2029)
Figure 58. Global Injection Influenza Vaccine Price (US$/Unit) by Application (2018-2029)
Figure 59. Injection Influenza Vaccine Value Chain
Figure 60. Injection Influenza Vaccine Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs